

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.12546713 |
| 2 | negative T cell selection (GO:0043383) | 5.65336936 |
| 3 | negative thymic T cell selection (GO:0045060) | 5.26740736 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.24110215 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.24110215 |
| 6 | positive thymic T cell selection (GO:0045059) | 5.01348066 |
| 7 | leukocyte aggregation (GO:0070486) | 4.97195668 |
| 8 | positive T cell selection (GO:0043368) | 4.76644992 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.75436246 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.50816217 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.47887286 |
| 12 | interferon-gamma production (GO:0032609) | 4.47599443 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.47019394 |
| 14 | thymic T cell selection (GO:0045061) | 4.41281346 |
| 15 | T cell selection (GO:0045058) | 4.40558492 |
| 16 | regulation of T cell tolerance induction (GO:0002664) | 4.36017700 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33261420 |
| 18 | T cell migration (GO:0072678) | 4.30763895 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22345540 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.18783239 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.18783239 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.11775866 |
| 23 | response to interleukin-15 (GO:0070672) | 4.04353769 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 3.99648633 |
| 25 | tolerance induction (GO:0002507) | 3.94394255 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92949410 |
| 27 | response to peptidoglycan (GO:0032494) | 3.89952921 |
| 28 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.89367915 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 3.88974653 |
| 30 | T cell costimulation (GO:0031295) | 3.85991130 |
| 31 | lymphocyte costimulation (GO:0031294) | 3.79558091 |
| 32 | T cell receptor signaling pathway (GO:0050852) | 3.73566164 |
| 33 | activated T cell proliferation (GO:0050798) | 3.69904237 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.65758635 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.65130225 |
| 36 | detection of other organism (GO:0098543) | 3.64064149 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.63446027 |
| 38 | detection of bacterium (GO:0016045) | 3.56579721 |
| 39 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.54895045 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.52934838 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.52595249 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.51442867 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.51442867 |
| 44 | mast cell activation (GO:0045576) | 3.50266687 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 3.48415441 |
| 46 | response to type I interferon (GO:0034340) | 3.48235121 |
| 47 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.45114418 |
| 48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42164838 |
| 49 | response to host immune response (GO:0052572) | 3.42164838 |
| 50 | positive regulation of interleukin-2 production (GO:0032743) | 3.41199561 |
| 51 | B cell mediated immunity (GO:0019724) | 3.37614845 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.32991016 |
| 53 | leukocyte cell-cell adhesion (GO:0007159) | 3.31659931 |
| 54 | positive regulation of tolerance induction (GO:0002645) | 3.31297976 |
| 55 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.30527656 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.29256740 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.29035087 |
| 58 | response to host (GO:0075136) | 3.29035087 |
| 59 | response to host defenses (GO:0052200) | 3.29035087 |
| 60 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.26588308 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25707891 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 3.16966520 |
| 63 | positive regulation of isotype switching (GO:0045830) | 3.16375612 |
| 64 | regulation of B cell differentiation (GO:0045577) | 3.11357577 |
| 65 | heterotypic cell-cell adhesion (GO:0034113) | 3.10841851 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10547425 |
| 67 | cellular response to zinc ion (GO:0071294) | 3.09862039 |
| 68 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09411493 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 3.08127047 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.05725479 |
| 71 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.05725479 |
| 72 | cellular extravasation (GO:0045123) | 3.02781156 |
| 73 | detection of external biotic stimulus (GO:0098581) | 3.01422587 |
| 74 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.01002839 |
| 75 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.01002839 |
| 76 | membrane raft organization (GO:0031579) | 3.00259007 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99864029 |
| 78 | defense response to protozoan (GO:0042832) | 2.97891371 |
| 79 | neutrophil activation involved in immune response (GO:0002283) | 2.97470464 |
| 80 | germinal center formation (GO:0002467) | 2.96206982 |
| 81 | neutrophil activation (GO:0042119) | 2.95259239 |
| 82 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.94365607 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.93093353 |
| 84 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89893936 |
| 85 | positive regulation of interferon-alpha production (GO:0032727) | 2.88306980 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.86712644 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.86592538 |
| 88 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.85565186 |
| 89 | NIK/NF-kappaB signaling (GO:0038061) | 2.85203561 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83934439 |
| 91 | response to protozoan (GO:0001562) | 2.83836917 |
| 92 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.83269030 |
| 93 | myeloid dendritic cell activation (GO:0001773) | 2.82132202 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 2.80240030 |
| 95 | T cell homeostasis (GO:0043029) | 2.79555704 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 2.79489194 |
| 97 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78838102 |
| 98 | T cell proliferation (GO:0042098) | 2.78627490 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.78105184 |
| 100 | leukocyte degranulation (GO:0043299) | 2.78041150 |
| 101 | alpha-beta T cell activation (GO:0046631) | 2.77768284 |
| 102 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77279980 |
| 103 | modulation by symbiont of host defense response (GO:0052031) | 2.77279980 |
| 104 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77279980 |
| 105 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77279980 |
| 106 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77279980 |
| 107 | modulation by symbiont of host immune response (GO:0052553) | 2.77279980 |
| 108 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75036179 |
| 109 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74610053 |
| 110 | regulation of isotype switching (GO:0045191) | 2.72953650 |
| 111 | regulation of interferon-alpha production (GO:0032647) | 2.72819790 |
| 112 | detection of molecule of bacterial origin (GO:0032490) | 2.71739324 |
| 113 | granulocyte activation (GO:0036230) | 2.71297130 |
| 114 | positive regulation of granulocyte differentiation (GO:0030854) | 2.70971878 |
| 115 | positive regulation of macrophage differentiation (GO:0045651) | 2.70928173 |
| 116 | positive regulation of mast cell activation (GO:0033005) | 2.70386605 |
| 117 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70182048 |
| 118 | positive regulation of DNA recombination (GO:0045911) | 2.68378181 |
| 119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.66529463 |
| 120 | lymphocyte homeostasis (GO:0002260) | 2.65871408 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.65633335 |
| 122 | B cell homeostasis (GO:0001782) | 2.65176178 |
| 123 | cellular defense response (GO:0006968) | 2.63810247 |
| 124 | mast cell activation involved in immune response (GO:0002279) | 2.63227443 |
| 125 | mast cell degranulation (GO:0043303) | 2.63227443 |
| 126 | natural killer cell activation (GO:0030101) | 2.62868743 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.62617551 |
| 128 | alpha-beta T cell differentiation (GO:0046632) | 2.61831231 |
| 129 | negative regulation of T cell mediated immunity (GO:0002710) | 2.59980263 |
| 130 | respiratory burst (GO:0045730) | 2.59944394 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.59086287 |
| 132 | positive regulation of B cell mediated immunity (GO:0002714) | 2.59086287 |
| 133 | T cell differentiation (GO:0030217) | 2.58678106 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.58621876 |
| 135 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.56512813 |
| 136 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.56415452 |
| 137 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.55028774 |
| 138 | lymph node development (GO:0048535) | 2.54168523 |
| 139 | myeloid dendritic cell differentiation (GO:0043011) | 2.52393609 |
| 140 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.51688872 |
| 141 | mature B cell differentiation (GO:0002335) | 2.51451148 |
| 142 | B cell proliferation (GO:0042100) | 2.50970821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.78632515 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.64793062 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.18197706 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80002962 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66844193 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.65363536 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41356293 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.34322761 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.33623905 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.18100616 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.94012096 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.93110717 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85702126 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.78556594 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71230055 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.70526446 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.69196253 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.63394721 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57479066 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.54112443 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51038019 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42827539 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.41693129 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.29310140 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.27288489 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13152980 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99425675 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95387298 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94956789 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84428745 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82929712 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81636776 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78682885 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78428525 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74708531 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73783101 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70805880 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68392763 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66806189 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62207349 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61041409 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58419219 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57908743 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54681709 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48738831 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48409516 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46163398 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45513353 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44326869 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41372298 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.39959119 |
| 52 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39427436 |
| 53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32562057 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32535752 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30961295 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28604169 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28343322 |
| 58 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.27916165 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27111624 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26440898 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24740499 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19097583 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18260105 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18203753 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15694131 |
| 66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15494551 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12905055 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08858384 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07144943 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06774571 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05728941 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04052882 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03176776 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00030837 |
| 75 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.00015721 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99627085 |
| 77 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.99377389 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99142224 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98398860 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97016545 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96952339 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96299468 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95543419 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95404729 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.92787438 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92319371 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91650888 |
| 88 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91577073 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91150952 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90237161 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89997192 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89096436 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87620138 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87613602 |
| 95 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86625327 |
| 96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.86298467 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86200527 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85831565 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85776744 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84157595 |
| 101 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.83614872 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83589368 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83112287 |
| 104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83112287 |
| 105 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81120971 |
| 106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80924891 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80606384 |
| 108 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80475490 |
| 109 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.80424035 |
| 110 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80353621 |
| 111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80254973 |
| 112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79537652 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78916846 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78478352 |
| 115 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77548544 |
| 116 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77241266 |
| 117 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.74971009 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74717026 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74717026 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74608398 |
| 121 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.73127179 |
| 122 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.72916114 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71477456 |
| 124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70719568 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68616593 |
| 126 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68165053 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66231573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.44356578 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.37914511 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.24765506 |
| 4 | MP0003303_peritoneal_inflammation | 3.20120511 |
| 5 | MP0000685_abnormal_immune_system | 3.03171262 |
| 6 | MP0001790_abnormal_immune_system | 2.88161865 |
| 7 | MP0005387_immune_system_phenotype | 2.88161865 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.85864442 |
| 9 | MP0001800_abnormal_humoral_immune | 2.85359597 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.58841533 |
| 11 | MP0003436_decreased_susceptibility_to | 2.53971610 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.51602478 |
| 13 | MP0002723_abnormal_immune_serum | 2.48678003 |
| 14 | MP0001819_abnormal_immune_cell | 2.48418101 |
| 15 | MP0002933_joint_inflammation | 2.39814577 |
| 16 | MP0009785_altered_susceptibility_to | 2.39157080 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.35011717 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.34908687 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.24760606 |
| 20 | MP0002419_abnormal_innate_immunity | 2.24583942 |
| 21 | MP0002398_abnormal_bone_marrow | 2.24295696 |
| 22 | MP0005025_abnormal_response_to | 2.19429132 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.16869330 |
| 24 | MP0002405_respiratory_system_inflammati | 2.15930993 |
| 25 | MP0003724_increased_susceptibility_to | 2.10354251 |
| 26 | MP0006082_CNS_inflammation | 2.04487046 |
| 27 | MP0000716_abnormal_immune_system | 2.02453028 |
| 28 | MP0004510_myositis | 1.99060699 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.98004588 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.92857423 |
| 31 | MP0002006_tumorigenesis | 1.91758077 |
| 32 | MP0004947_skin_inflammation | 1.84209710 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.82862930 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.82719348 |
| 35 | MP0000569_abnormal_digit_pigmentation | 1.77274750 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.74951264 |
| 37 | MP0003279_aneurysm | 1.73331089 |
| 38 | MP0002722_abnormal_immune_system | 1.71246001 |
| 39 | MP0005451_abnormal_body_composition | 1.70885545 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.69956759 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.60470421 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.59897064 |
| 43 | MP0002429_abnormal_blood_cell | 1.59313700 |
| 44 | MP0003448_altered_tumor_morphology | 1.50189013 |
| 45 | MP0003828_pulmonary_edema | 1.48167741 |
| 46 | MP0001853_heart_inflammation | 1.47975945 |
| 47 | MP0001873_stomach_inflammation | 1.42631924 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.40558240 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.37378724 |
| 50 | MP0008260_abnormal_autophagy | 1.36846536 |
| 51 | MP0003091_abnormal_cell_migration | 1.36530687 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.35601063 |
| 53 | MP0000858_altered_metastatic_potential | 1.35461377 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.34442135 |
| 55 | MP0003075_altered_response_to | 1.29029073 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.27916115 |
| 57 | MP0001851_eye_inflammation | 1.22437814 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.19426028 |
| 59 | MP0009764_decreased_sensitivity_to | 1.15736031 |
| 60 | MP0000343_altered_response_to | 1.12801164 |
| 61 | MP0009278_abnormal_bone_marrow | 1.09571664 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.07119628 |
| 63 | MP0003045_fibrosis | 1.04383662 |
| 64 | MP0005275_abnormal_skin_tensile | 1.03753730 |
| 65 | MP0005390_skeleton_phenotype | 1.03551468 |
| 66 | MP0005023_abnormal_wound_healing | 1.02603685 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.01512016 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.01081795 |
| 69 | MP0000604_amyloidosis | 0.99269280 |
| 70 | MP0009763_increased_sensitivity_to | 0.99259822 |
| 71 | MP0005166_decreased_susceptibility_to | 0.99251312 |
| 72 | MP0005164_abnormal_response_to | 0.98163108 |
| 73 | MP0005174_abnormal_tail_pigmentation | 0.97951690 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.97916522 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.97916522 |
| 76 | MP0000920_abnormal_myelination | 0.95949880 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.95358659 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 0.94737119 |
| 79 | MP0000733_abnormal_muscle_development | 0.94384467 |
| 80 | MP0005310_abnormal_salivary_gland | 0.93848466 |
| 81 | MP0004084_abnormal_cardiac_muscle | 0.92119042 |
| 82 | MP0003866_abnormal_defecation | 0.91160511 |
| 83 | MP0003795_abnormal_bone_structure | 0.90814425 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.88718121 |
| 85 | MP0009840_abnormal_foam_cell | 0.86528808 |
| 86 | MP0002009_preneoplasia | 0.86010676 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.84168021 |
| 88 | MP0006054_spinal_hemorrhage | 0.83624293 |
| 89 | MP0004883_abnormal_blood_vessel | 0.82643275 |
| 90 | MP0001243_abnormal_dermal_layer | 0.82600509 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.81923075 |
| 92 | MP0001958_emphysema | 0.81246978 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.80877601 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.79877071 |
| 95 | MP0008469_abnormal_protein_level | 0.79876813 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.79174213 |
| 97 | MP0001663_abnormal_digestive_system | 0.77836861 |
| 98 | MP0000490_abnormal_crypts_of | 0.77792271 |
| 99 | MP0002132_abnormal_respiratory_system | 0.73332054 |
| 100 | MP0001542_abnormal_bone_strength | 0.70138927 |
| 101 | MP0004130_abnormal_muscle_cell | 0.69525964 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.67185720 |
| 103 | MP0005165_increased_susceptibility_to | 0.65697051 |
| 104 | MP0005503_abnormal_tendon_morphology | 0.65313802 |
| 105 | MP0004134_abnormal_chest_morphology | 0.65119123 |
| 106 | MP0000249_abnormal_blood_vessel | 0.64747221 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.64571078 |
| 108 | MP0008775_abnormal_heart_ventricle | 0.63101161 |
| 109 | MP0010630_abnormal_cardiac_muscle | 0.62134565 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.61979683 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.61216801 |
| 112 | MP0005623_abnormal_meninges_morphology | 0.60924655 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.60668826 |
| 114 | MP0008874_decreased_physiological_sensi | 0.60257191 |
| 115 | MP0008004_abnormal_stomach_pH | 0.59668976 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.59331281 |
| 117 | MP0004381_abnormal_hair_follicle | 0.58529652 |
| 118 | MP0002972_abnormal_cardiac_muscle | 0.57800037 |
| 119 | MP0004087_abnormal_muscle_fiber | 0.57261745 |
| 120 | MP0003690_abnormal_glial_cell | 0.54732743 |
| 121 | MP0005621_abnormal_cell_physiology | 0.54448615 |
| 122 | MP0005330_cardiomyopathy | 0.53723466 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.53638976 |
| 124 | MP0002113_abnormal_skeleton_development | 0.51553646 |
| 125 | MP0001544_abnormal_cardiovascular_syste | 0.50602510 |
| 126 | MP0003329_amyloid_beta_deposits | 0.47972808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.30298048 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.09741218 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.56895374 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.25780434 |
| 5 | Recurrent viral infections (HP:0004429) | 4.08018752 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.06179302 |
| 7 | Stomatitis (HP:0010280) | 3.98187207 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85350799 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.49343537 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 3.47650242 |
| 11 | Abnormality of T cells (HP:0002843) | 3.47361962 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 3.46987905 |
| 13 | Myositis (HP:0100614) | 3.42892095 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.26730356 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.26730356 |
| 16 | Thyroiditis (HP:0100646) | 3.25474146 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.22912524 |
| 18 | Eosinophilia (HP:0001880) | 3.21127393 |
| 19 | Obstructive lung disease (HP:0006536) | 3.14745618 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14745618 |
| 21 | Combined immunodeficiency (HP:0005387) | 3.05084089 |
| 22 | Urticaria (HP:0001025) | 3.01782872 |
| 23 | Meningitis (HP:0001287) | 2.99286931 |
| 24 | B lymphocytopenia (HP:0010976) | 2.97149633 |
| 25 | Abnormality of B cell number (HP:0010975) | 2.97149633 |
| 26 | Recurrent skin infections (HP:0001581) | 2.96744692 |
| 27 | Chronic otitis media (HP:0000389) | 2.91999401 |
| 28 | Abnormality of eosinophils (HP:0001879) | 2.91863117 |
| 29 | Cellulitis (HP:0100658) | 2.91223569 |
| 30 | Leukocytosis (HP:0001974) | 2.91212381 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.90306975 |
| 32 | IgG deficiency (HP:0004315) | 2.86500022 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.83233973 |
| 34 | Optic neuritis (HP:0100653) | 2.83233973 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.82607916 |
| 36 | IgM deficiency (HP:0002850) | 2.80580020 |
| 37 | Epistaxis (HP:0000421) | 2.72685954 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71879983 |
| 39 | Vasculitis (HP:0002633) | 2.69045653 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68566132 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68566132 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68566132 |
| 43 | Colitis (HP:0002583) | 2.67269756 |
| 44 | Petechiae (HP:0000967) | 2.67030672 |
| 45 | Premature rupture of membranes (HP:0001788) | 2.65950851 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.65724035 |
| 47 | Aortic dissection (HP:0002647) | 2.65302084 |
| 48 | Increased density of long bones (HP:0006392) | 2.58864059 |
| 49 | Orchitis (HP:0100796) | 2.56021590 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.53307875 |
| 51 | Granulocytopenia (HP:0001913) | 2.52122372 |
| 52 | Gingival bleeding (HP:0000225) | 2.51535093 |
| 53 | Lymphopenia (HP:0001888) | 2.47375137 |
| 54 | Verrucae (HP:0200043) | 2.37440341 |
| 55 | Papilloma (HP:0012740) | 2.37440341 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.37403178 |
| 57 | Increased IgE level (HP:0003212) | 2.34679708 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33936271 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.33841677 |
| 60 | Aortic aneurysm (HP:0004942) | 2.32789697 |
| 61 | Amyloidosis (HP:0011034) | 2.32731826 |
| 62 | Fatigue (HP:0012378) | 2.31314440 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.30723080 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.27247696 |
| 65 | Abnormality of the fingertips (HP:0001211) | 2.25960240 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.25831629 |
| 67 | Osteolytic defects of the hand bones (HP:0009699) | 2.25831629 |
| 68 | Hemoptysis (HP:0002105) | 2.25745347 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.24683121 |
| 70 | Dilatation of the ascending aorta (HP:0005111) | 2.22278734 |
| 71 | Protrusio acetabuli (HP:0003179) | 2.21371869 |
| 72 | Glomerulopathy (HP:0100820) | 2.19501002 |
| 73 | Chronic diarrhea (HP:0002028) | 2.18701586 |
| 74 | Persistence of primary teeth (HP:0006335) | 2.18387944 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.18265709 |
| 76 | Viral hepatitis (HP:0006562) | 2.17770668 |
| 77 | Skin rash (HP:0000988) | 2.16163717 |
| 78 | Pustule (HP:0200039) | 2.15756650 |
| 79 | Purpura (HP:0000979) | 2.15264826 |
| 80 | Nasal polyposis (HP:0100582) | 2.14215058 |
| 81 | Spondylolisthesis (HP:0003302) | 2.13987067 |
| 82 | Abnormality of T cell physiology (HP:0011840) | 2.13844153 |
| 83 | Gingivitis (HP:0000230) | 2.11229323 |
| 84 | Cerebral aneurysm (HP:0004944) | 2.10380719 |
| 85 | Emphysema (HP:0002097) | 2.09669996 |
| 86 | Loss of speech (HP:0002371) | 2.09618277 |
| 87 | Arterial thrombosis (HP:0004420) | 2.09443208 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.08060588 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07875899 |
| 90 | Pulmonary embolism (HP:0002204) | 2.07397936 |
| 91 | IgA deficiency (HP:0002720) | 2.06808308 |
| 92 | Abnormality of the pleura (HP:0002103) | 2.05175837 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.04858222 |
| 94 | Episodic fever (HP:0001954) | 2.03998051 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01601295 |
| 96 | Gastrointestinal infarctions (HP:0005244) | 2.01068427 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.00301882 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 1.99877268 |
| 99 | Arthralgia (HP:0002829) | 1.99269663 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.98700602 |
| 101 | Recurrent pneumonia (HP:0006532) | 1.98269777 |
| 102 | Chest pain (HP:0100749) | 1.97609616 |
| 103 | Gangrene (HP:0100758) | 1.97199670 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 1.95828184 |
| 105 | Vertebral compression fractures (HP:0002953) | 1.95820908 |
| 106 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93960095 |
| 107 | Disinhibition (HP:0000734) | 1.92904458 |
| 108 | Absent frontal sinuses (HP:0002688) | 1.92176336 |
| 109 | Restrictive lung disease (HP:0002091) | 1.91671338 |
| 110 | Abnormal platelet volume (HP:0011876) | 1.85547782 |
| 111 | Encephalitis (HP:0002383) | 1.84154375 |
| 112 | Osteomyelitis (HP:0002754) | 1.83730557 |
| 113 | Hypoplasia of the thymus (HP:0000778) | 1.83131070 |
| 114 | Periodontitis (HP:0000704) | 1.81201008 |
| 115 | Spinal cord lesions (HP:0100561) | 1.80568794 |
| 116 | Syringomyelia (HP:0003396) | 1.80568794 |
| 117 | Acrocyanosis (HP:0001063) | 1.78949961 |
| 118 | Abnormality of the nasal mucosa (HP:0000433) | 1.78684831 |
| 119 | Peritonitis (HP:0002586) | 1.77985026 |
| 120 | Sepsis (HP:0100806) | 1.76650211 |
| 121 | Keratoconjunctivitis sicca (HP:0001097) | 1.76496973 |
| 122 | Skin ulcer (HP:0200042) | 1.75676553 |
| 123 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74282360 |
| 124 | Increased IgM level (HP:0003496) | 1.73277975 |
| 125 | Abnormality of the prostate (HP:0008775) | 1.72744333 |
| 126 | Recurrent sinusitis (HP:0011108) | 1.71304221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.90939976 |
| 2 | MAP4K1 | 4.80567536 |
| 3 | ERN1 | 3.08185892 |
| 4 | PRPF4B | 3.00591329 |
| 5 | STK10 | 2.78217049 |
| 6 | ITK | 2.66798512 |
| 7 | BLK | 2.60154839 |
| 8 | JAK3 | 2.53969391 |
| 9 | ZAP70 | 2.20487386 |
| 10 | TYK2 | 2.08087973 |
| 11 | EPHB1 | 2.02320746 |
| 12 | JAK1 | 1.99545704 |
| 13 | TTN | 1.93670109 |
| 14 | MAP2K3 | 1.93290525 |
| 15 | DMPK | 1.92178046 |
| 16 | IRAK4 | 1.90603347 |
| 17 | IKBKE | 1.83380086 |
| 18 | CSK | 1.83088894 |
| 19 | TEC | 1.80456853 |
| 20 | LCK | 1.78626988 |
| 21 | TBK1 | 1.78276865 |
| 22 | MAP3K14 | 1.78234813 |
| 23 | HCK | 1.73430249 |
| 24 | CLK1 | 1.70537081 |
| 25 | NLK | 1.69017780 |
| 26 | KIT | 1.56283575 |
| 27 | FGFR3 | 1.55536446 |
| 28 | SYK | 1.52850629 |
| 29 | STK24 | 1.50428266 |
| 30 | MAP3K11 | 1.46958004 |
| 31 | BMPR2 | 1.44072600 |
| 32 | BTK | 1.41587859 |
| 33 | TESK2 | 1.40169400 |
| 34 | MAP3K3 | 1.39484062 |
| 35 | TRIB3 | 1.37252681 |
| 36 | TRPM7 | 1.36448085 |
| 37 | GRK6 | 1.34886820 |
| 38 | FES | 1.34649479 |
| 39 | LRRK2 | 1.32707458 |
| 40 | PRKCQ | 1.30892696 |
| 41 | NME2 | 1.30759786 |
| 42 | TAOK2 | 1.29785984 |
| 43 | SCYL2 | 1.28403076 |
| 44 | FGFR4 | 1.23025231 |
| 45 | MAP3K13 | 1.22640026 |
| 46 | IKBKB | 1.19705963 |
| 47 | ARAF | 1.17611795 |
| 48 | PKN2 | 1.16370690 |
| 49 | MARK3 | 1.11741221 |
| 50 | CSF1R | 1.11385205 |
| 51 | MOS | 1.07902288 |
| 52 | SMG1 | 1.07581204 |
| 53 | TGFBR2 | 1.04833524 |
| 54 | MST4 | 1.03819393 |
| 55 | NEK9 | 1.00893395 |
| 56 | MAP3K1 | 0.99631612 |
| 57 | RPS6KA4 | 0.99076224 |
| 58 | LYN | 0.96510249 |
| 59 | MAP3K10 | 0.95556982 |
| 60 | RIPK4 | 0.95278326 |
| 61 | PRKCH | 0.95207706 |
| 62 | CDK12 | 0.89753789 |
| 63 | MATK | 0.89434436 |
| 64 | PIM2 | 0.86546169 |
| 65 | MAPKAPK5 | 0.86055273 |
| 66 | TAOK1 | 0.85615789 |
| 67 | PIM1 | 0.85561338 |
| 68 | PDGFRB | 0.83745544 |
| 69 | LIMK1 | 0.81873374 |
| 70 | STK4 | 0.79205755 |
| 71 | SIK2 | 0.78114009 |
| 72 | IRAK3 | 0.78030105 |
| 73 | PIK3CG | 0.75983696 |
| 74 | CDK4 | 0.74088118 |
| 75 | EPHA3 | 0.73928612 |
| 76 | MAPK7 | 0.73738560 |
| 77 | STK3 | 0.72779239 |
| 78 | TESK1 | 0.68458608 |
| 79 | NUAK1 | 0.68129487 |
| 80 | HIPK2 | 0.67623340 |
| 81 | JAK2 | 0.67495178 |
| 82 | MAPK11 | 0.66653294 |
| 83 | PRKD1 | 0.66167169 |
| 84 | CDC42BPA | 0.65095148 |
| 85 | PIK3CA | 0.63636036 |
| 86 | FYN | 0.61738111 |
| 87 | PRKD2 | 0.61005784 |
| 88 | KDR | 0.59628917 |
| 89 | PDPK1 | 0.59216622 |
| 90 | EEF2K | 0.58992371 |
| 91 | PKN1 | 0.58969616 |
| 92 | ILK | 0.54985846 |
| 93 | CHUK | 0.53363585 |
| 94 | FGR | 0.52389391 |
| 95 | INSR | 0.52156791 |
| 96 | CDK6 | 0.51661754 |
| 97 | MAPKAPK2 | 0.48848131 |
| 98 | MELK | 0.48587172 |
| 99 | MAP3K5 | 0.47786349 |
| 100 | CDK9 | 0.47404809 |
| 101 | BCKDK | 0.46865767 |
| 102 | MAP3K8 | 0.46676236 |
| 103 | MARK2 | 0.44597296 |
| 104 | MAPK4 | 0.44460856 |
| 105 | RAF1 | 0.44035969 |
| 106 | KSR2 | 0.43425775 |
| 107 | WNK1 | 0.43365783 |
| 108 | RPS6KA5 | 0.42276779 |
| 109 | TAOK3 | 0.41408841 |
| 110 | ABL1 | 0.40833352 |
| 111 | IRAK1 | 0.40711816 |
| 112 | CAMK1D | 0.39912393 |
| 113 | MAPK12 | 0.38195616 |
| 114 | YES1 | 0.38043825 |
| 115 | TNK2 | 0.37911913 |
| 116 | IGF1R | 0.37179580 |
| 117 | PDK1 | 0.36753046 |
| 118 | CDK19 | 0.35804264 |
| 119 | EGFR | 0.35667432 |
| 120 | ROCK2 | 0.34157175 |
| 121 | ALK | 0.33953553 |
| 122 | SIK3 | 0.33912293 |
| 123 | CAMK1G | 0.33077151 |
| 124 | RPS6KA6 | 0.31846142 |
| 125 | PTK2B | 0.31500075 |
| 126 | GRK7 | 0.30282226 |
| 127 | PTK6 | 0.30141332 |
| 128 | SIK1 | 0.29918816 |
| 129 | FLT3 | 0.29053475 |
| 130 | PAK3 | 0.29012252 |
| 131 | ROCK1 | 0.28698624 |
| 132 | CAMKK2 | 0.27895568 |
| 133 | PRKCD | 0.27522652 |
| 134 | CAMKK1 | 0.24351360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.67979435 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.53951657 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26386047 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24503742 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20947222 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17899564 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13235215 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.11447322 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09843900 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05816416 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.00507329 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.98611268 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96416120 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95116190 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78674301 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65137813 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60115522 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.55965721 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46925266 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46067633 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40816221 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.40129586 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38752259 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37755311 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36907634 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35533913 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30372917 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.26397562 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26131143 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.23482119 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23333958 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.23165941 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21892057 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17754847 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.17754261 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15643991 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15443162 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.14336824 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14170719 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12758042 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11734835 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.11597910 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10595344 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07063402 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.05968396 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03310897 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.01953910 |
| 48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.98872079 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93597464 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91919518 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.91563909 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91178047 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 0.88545510 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88174089 |
| 55 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87680176 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86304103 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85496049 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83781293 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83565911 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83499640 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82637682 |
| 62 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81867649 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78753628 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78414450 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76817578 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75482235 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74896288 |
| 68 | * Endocytosis_Homo sapiens_hsa04144 | 0.74592214 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74223776 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.73433718 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72978154 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72868412 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72069625 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72021673 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68870743 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.66538321 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66403944 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64911287 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64485359 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64236506 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.62720653 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.62296631 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62110064 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.62108077 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62022740 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60206251 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59874170 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58105594 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.57224845 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55463379 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54527092 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52728344 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52132881 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51483299 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51381423 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50454725 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46824315 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45990415 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.45618589 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44072093 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42482282 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41607124 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40291930 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.39782307 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39038627 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37395084 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37322058 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36239204 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34280199 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33930686 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32843708 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30843766 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29389154 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28648011 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26444437 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.25490642 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23350864 |

